Market Cap 2.21M
Revenue (ttm) 2.52M
Net Income (ttm) -58.69M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,328.97%
Debt to Equity Ratio 0.00
Volume 65,900
Avg Vol 85,252
Day's Range N/A - N/A
Shares Out 1.56M
Stochastic %K 38%
Beta 3.45
Analysts Strong Buy
Price Target N/A

Company Profile

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, I...

Industry: Biotechnology
Sector: Healthcare
Phone: 513 620 4101
Address:
201 East Fifth Street, Suite 1900, Cincinnati, United States
DJay89
DJay89 Jan. 30 at 5:03 PM
$ONCO when is the reverse split AGAIN???
1 · Reply
oceanviewhi
oceanviewhi Jan. 30 at 2:55 AM
$IBRX In 2026, the relationship between ImmunityBio ($IBRX) and the company you're referring to—BeOne Medicines (formerly BeiGene)—is one of the most significant "Global BioShield" partnerships in the biotech industry. There is often confusion between BeOne Medicines ($ONC) and Onconetix ($ONCO) due to the similar tickers, but the "10,000 employee" giant you are asking about is definitely BeOne Medicines. Here is how this partnership benefits $IBRX in the USA, UK, and EU, especially regarding the upcoming NSCLC (Lung Cancer) approvals: • The BeOne/BeiGene Transition: BeiGene officially rebranded to BeOne Medicines (Nasdaq: ONC) in late 2024. This is the partner that has the 11,000+ person global workforce you mentioned. They are a "powerhouse" in oncology with a presence in over 45 countries across six continents.
1 · Reply
oceanviewhi
oceanviewhi Jan. 30 at 2:46 AM
$IBRX Streamlined Clinical Staff: Unlike AstraZeneca’s 90,000+ employees, Onconetix operates with a high-density clinical and statistical leadership team (including recent hires from CG Oncology and Morphic). This "lean" workforce can pivot study designs in weeks, whereas a company like $AZN might take months of committee meetings to adjust a trial protocol. 2. The Synergy: $IBRX Science + $ONCO Execution Onconetix is advancing specialized platforms like pelareorep (for gastrointestinal cancers). Combining $IBRX's ANKTIVA (the "engine") with Onconetix's tumor-targeting agents creates a high-velocity combo that doesn't need to wait for Big Pharma's massive 500-site Phase 3 trials to show value. Smaller, "hungrier" partners often get priority from trial investigators because they offer more innovative, flexible study designs. For NSCLC (Lung Cancer) and Gastrointestinal indications, this synergy could shave 18 months off the path to a Supplemental Biologics License Application (sBLA).
0 · Reply
DJay89
DJay89 Jan. 22 at 1:04 PM
$ONCO rest in peace to this trash as well
1 · Reply
Tracey11
Tracey11 Jan. 22 at 11:30 AM
0 · Reply
DARKP00L
DARKP00L Jan. 22 at 11:23 AM
0 · Reply
DARKP00L
DARKP00L Jan. 22 at 11:23 AM
0 · Reply
DARKP00L
DARKP00L Jan. 22 at 11:12 AM
🚨$1K to $5,000k Trading Challenge 🚨 Ready to prove your trading skills? We’re launching a high-stakes challenge to grow a $1K account into $5K! [Link in Bio] $IOTR Stay $SXTP Lit $ONCO Trader $PSTV
0 · Reply
DARKP00L
DARKP00L Jan. 22 at 10:54 AM
0 · Reply
DARKP00L
DARKP00L Jan. 22 at 10:41 AM
0 · Reply
Latest News on ONCO
Onco-Innovations Uplists to Cboe Canada

May 22, 2025, 10:00 AM EDT - 9 months ago

Onco-Innovations Uplists to Cboe Canada


Crude Oil Rises; Onconetix Shares Spike Higher

Sep 27, 2024, 2:41 PM EDT - 1 year ago

Crude Oil Rises; Onconetix Shares Spike Higher


Blue Water Biotech Issues Letter to Shareholders

Oct 30, 2023, 7:00 AM EDT - 2 years ago

Blue Water Biotech Issues Letter to Shareholders


DJay89
DJay89 Jan. 30 at 5:03 PM
$ONCO when is the reverse split AGAIN???
1 · Reply
oceanviewhi
oceanviewhi Jan. 30 at 2:55 AM
$IBRX In 2026, the relationship between ImmunityBio ($IBRX) and the company you're referring to—BeOne Medicines (formerly BeiGene)—is one of the most significant "Global BioShield" partnerships in the biotech industry. There is often confusion between BeOne Medicines ($ONC) and Onconetix ($ONCO) due to the similar tickers, but the "10,000 employee" giant you are asking about is definitely BeOne Medicines. Here is how this partnership benefits $IBRX in the USA, UK, and EU, especially regarding the upcoming NSCLC (Lung Cancer) approvals: • The BeOne/BeiGene Transition: BeiGene officially rebranded to BeOne Medicines (Nasdaq: ONC) in late 2024. This is the partner that has the 11,000+ person global workforce you mentioned. They are a "powerhouse" in oncology with a presence in over 45 countries across six continents.
1 · Reply
oceanviewhi
oceanviewhi Jan. 30 at 2:46 AM
$IBRX Streamlined Clinical Staff: Unlike AstraZeneca’s 90,000+ employees, Onconetix operates with a high-density clinical and statistical leadership team (including recent hires from CG Oncology and Morphic). This "lean" workforce can pivot study designs in weeks, whereas a company like $AZN might take months of committee meetings to adjust a trial protocol. 2. The Synergy: $IBRX Science + $ONCO Execution Onconetix is advancing specialized platforms like pelareorep (for gastrointestinal cancers). Combining $IBRX's ANKTIVA (the "engine") with Onconetix's tumor-targeting agents creates a high-velocity combo that doesn't need to wait for Big Pharma's massive 500-site Phase 3 trials to show value. Smaller, "hungrier" partners often get priority from trial investigators because they offer more innovative, flexible study designs. For NSCLC (Lung Cancer) and Gastrointestinal indications, this synergy could shave 18 months off the path to a Supplemental Biologics License Application (sBLA).
0 · Reply
DJay89
DJay89 Jan. 22 at 1:04 PM
$ONCO rest in peace to this trash as well
1 · Reply
Tracey11
Tracey11 Jan. 22 at 11:30 AM
0 · Reply
DARKP00L
DARKP00L Jan. 22 at 11:23 AM
0 · Reply
DARKP00L
DARKP00L Jan. 22 at 11:23 AM
0 · Reply
DARKP00L
DARKP00L Jan. 22 at 11:12 AM
🚨$1K to $5,000k Trading Challenge 🚨 Ready to prove your trading skills? We’re launching a high-stakes challenge to grow a $1K account into $5K! [Link in Bio] $IOTR Stay $SXTP Lit $ONCO Trader $PSTV
0 · Reply
DARKP00L
DARKP00L Jan. 22 at 10:54 AM
0 · Reply
DARKP00L
DARKP00L Jan. 22 at 10:41 AM
0 · Reply
DARKP00L
DARKP00L Jan. 22 at 10:40 AM
🚨 DarkpoolAI Live Stock Scanner! 🚨 👉 [https://x.com/DarkpoolAI/live] [Link in Bio] $IOTR Pull $SXTP up $ONCO We lit $PSTV
0 · Reply
DARKP00L
DARKP00L Jan. 22 at 10:33 AM
$IOTR just look at that chart! You can add our tradingview algo to your chart and set your own alerts to never miss a parabolic move again! [Link in Bio] $SXTP We $PSTV Stay $ONCO Lit
0 · Reply
KingZoroReaps
KingZoroReaps Jan. 22 at 5:48 AM
$ONCO swinging this.
0 · Reply
Taco16
Taco16 Jan. 21 at 8:53 PM
$ONCO dilution?
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Jan. 20 at 8:18 PM
⏳️⌛️ Potential swing ideas 💡 ✅️ $OPAD recent offering at $1.80, previously secured $4.8M AI robot sales deal, recent reveres split, ultra small float, company offers corporate business training, consulting, advisory and transaction services in China , Alliance global partners price target 3.50 ✅️ $ONCO company focuses on research, developments and commercialization of innovative solutions in men's health oncology (cancer diagnostics/treatments), key assets include: 1) Proclarix, an in vitro protein-based diagnostic test for prostate cancer, 2) ENTADFI, a combining finasteride and tadalafil , FDA-approved once daily for benign prostatic hyperplasia (BPH), does have mixed shelf, be mindful on next spike ✅️ $CGC mj one of the largest Canadian cannabis companies focuses on production, distribution, and sale of medical and recreational cannabis, also carries non-THC products including hemp-derived wellness goods, Bernstein price target $2.50, does have mixed shelf
2 · Reply
drypow
drypow Jan. 20 at 7:44 PM
$ONCO with a little buying pressure this stock can fly! Nice rip earlier today!
0 · Reply
powerhour1
powerhour1 Jan. 20 at 7:27 PM
$ONCO she wants to run, let her go!
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Jan. 16 at 7:35 PM
⌛️⏳️ Potential swing ideas 💡💡 ✅️ $ONCO company focuses on research, developments and commercialization of innovative solutions in men's health oncology (cancer diagnostics/treatments), key assets include: 1) Proclarix, an in vitro protein-based diagnostic test for prostate cancer, 2) ENTADFI, a combining finasteride and tadalafil , FDA-approved once daily for benign prostatic hyperplasia (BPH), does have mixed shelf, be mindful on next spike ✅️ $APM recently unveiled new plasma microRNA biomarket data at Alzheimer's conference, company focuses on targeting disease with unmet medical needs in oncology and infectious diseases. ✅️ $NNVC recently signed Master services agreements with Only Orphans Cote, company focuses on discovering and developing broad-spectrum antiviral therapeutics, former runner, Alliance Global buy rating
2 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Jan. 16 at 2:28 PM
🌅 Watchlist part 2 ✅ $SVRE $1.80 support; if above $2.00, potential to $2.40 / $2.60 ✅ $CGTL low $4.30 support; if above $4.50, potential to $5.00 / $5.40 ✅ $IBRX mid $4.50 support; if above $5.00, potential to $5.30 / $5.50 🚨 Not ideal for swing accumulation at current prices ✅ Ideal long entry near low current support 🎯 Ideal stop loss below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $BYND $ONCO still in swing accumulation phase 🎯🎯 Goal is GR🤑🤑N, not GR🥵🥵D
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Jan. 16 at 3:37 AM
🌅 Watchlist part 2 ✅ $ASBP 1-for-40 reverse split, new price ~$2.00 ✅ $HUBC 1-for-15 reverse split, new price ~$4.65 ✅ $OCG 1-for-220 reverse split, new price ~$2.20 🚨 The above tickers are not ideal for swing accumulation at current prices ✅ Ideal long entry near low current support 🎯 Ideal stop loss below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $BYND $ONCO in swing accumulation phase 🎯🎯 Goal is GR🤑🤑N, not GR🥵🥵D
1 · Reply
ThatDudeWithNoMoney
ThatDudeWithNoMoney Jan. 12 at 10:16 PM
$ONCO shorts covered
0 · Reply
khaliddaman
khaliddaman Jan. 12 at 10:10 PM
0 · Reply